Insurance, Pharmaceutical Services
"Insurance, Pharmaceutical Services" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.
| Descriptor ID |
D007356
|
| MeSH Number(s) |
N03.219.521.576.343.575
|
| Concept/Terms |
Insurance, Pharmaceutical Services- Insurance, Pharmaceutical Services
- Pharmacy Services Insurance
- Pharmaceutic Services Insurance
- Pharmaceutical Services Insurance
- Insurance, Pharmaceutic Services
- Insurance, Pharmacy Services
Drug Benefit Plans- Drug Benefit Plans
- Drug Benefit Plan
- Plan, Drug Benefit
- Plans, Drug Benefit
|
Below are MeSH descriptors whose meaning is more general than "Insurance, Pharmaceutical Services".
Below are MeSH descriptors whose meaning is more specific than "Insurance, Pharmaceutical Services".
This graph shows the total number of publications written about "Insurance, Pharmaceutical Services" by people in this website by year, and whether "Insurance, Pharmaceutical Services" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insurance, Pharmaceutical Services" by people in Profiles.
-
Greenwood BC. Introduction: Pharmacy Reimbursement. J Manag Care Spec Pharm. 2020 Jun; 26(6):702.
-
Gor D, Lee TA, Schumock GT, Walton SM, Gerber BS, Nutescu EA, Touchette DR. Adherence and Persistence with DPP-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients with Chronic Kidney Disease: A Retrospective Claims Database Analysis. J Manag Care Spec Pharm. 2020 Jan; 26(1):67-75.
-
Albrecht J, Lebwohl M, Asgari MM, Bennett DD, Cook A, Evans CC, Green LJ, Hodge JA, Kourosh AS, Maloney ME, Howard LM, Olsen EA, Rosenberg SP, Rubin A, Stough DB, Taylor SC, Brod BA. The state and consequences of dermatology drug prices in the United States. J Am Acad Dermatol. 2016 Sep; 75(3):603-605.
-
Garcia MM, Angelini MC, Thomas T, Lenz K, Jeffrey P. Implementation of an opioid management initiative by a state Medicaid program. J Manag Care Spec Pharm. 2014 May; 20(5):447-54.
-
Jeffrey PL, Lenz K. The opiate dilemma. J Manag Care Spec Pharm. 2014 May; 20(5):437-8.
-
Fahey N. All contraceptives are not created equal. Med Care. 2013 Nov; 51(11):957-8.
-
Harrold LR, Briesacher BA, Peterson D, Beard A, Madden J, Zhang F, Gurwitz JH, Soumerai SB. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol. 2013 Feb; 40(2):137-43.
-
Shaffer ER, Sarfaty M, Ash AS. Contraceptive insurance mandates. Med Care. 2012 Jul; 50(7):559-61.
-
Magnusson BM, Sabik L, Chapman DA, Masho SW, Lafata JE, Bradley CJ, Lapane KL. Contraceptive insurance mandates and consistent contraceptive use among privately insured women. Med Care. 2012 Jul; 50(7):562-8.
-
Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011 Dec 01; 365(22):2088-97.